Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Long-COVID symptoms can last more than a year and change over time.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

More symptoms during initial COVID infection increase the risk of long-term effects.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Skin aging reflects overall body aging and can indicate internal health conditions.

A 13-year-old boy had flu-like symptoms and low platelets after a camping trip, with a confirmed diagnosis later.

Steroid hormones can help treat aging issues and improve health in elderly people.